ArticleFrontiers in medicine2025

Changes in lung function and exercise capacity are strong predictors of mortality in patients with IPF receiving antifibrotic therapy.

Ju Hyun Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.